COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-14
DOI
10.1038/s41375-021-01270-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib
- (2021) Tiziano Barbui et al. LEUKEMIA
- COVID-19 in persons with haematological cancers
- (2020) Wenjuan He et al. LEUKEMIA
- Multiple myeloma and COVID-19
- (2020) Binod Dhakal et al. LEUKEMIA
- Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience
- (2020) Anthony R. Mato et al. BLOOD
- Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL)
- (2020) Francesca Romana Mauro et al. LEUKEMIA
- Cancer increases risk of in-hospital death from COVID-19 in persons
- (2020) Qiubai Li et al. LEUKEMIA
- COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
- (2020) Lydia Scarfò et al. LEUKEMIA
- Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands
- (2020) Jaap van Doesum et al. LEUKEMIA
- COVID-19 among fit patients with CLL treated with venetoclax-based combinations
- (2020) Moritz Fürstenau et al. LEUKEMIA
- Reduction in the rate and improvement in the prognosis of COVID-19 in haematological patients over time
- (2020) Chiara Cattaneo et al. LEUKEMIA
- Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
- (2020) Francesco Passamonti et al. Lancet Haematology
- COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter
- (2020) Ankur Varma et al. LEUKEMIA
- COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey
- (2020) Massimo Breccia et al. LEUKEMIA
- Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines
- (2020) Christopher Pleyer et al. BLOOD
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ibrutinib may impair serological responses to influenza vaccination
- (2017) Abby P. Douglas et al. HAEMATOLOGICA
- Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies
- (2017) Janie Parrino et al. VACCINE
- Ibrutinib may impair serological responses to influenza vaccination
- (2017) Abby P. Douglas et al. HAEMATOLOGICA
- Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib
- (2016) Clare Sun et al. JAMA Oncology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started